Verve Therapeutics, Inc. (VERV) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verve Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Verve Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $83.5 M, a 7.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $83.5 M -$6.48 M -7.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $85.3 M -$6.58 M -7.16% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $87 M -$4.29 M -4.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $88.8 M +$87.9 M +10480% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $90 M +$88.7 M +6617% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $91.9 M +$90 M +4896% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $91.3 M +$89 M +3811% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $839 K Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.34 M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.84 M +$1.84 M Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.34 M Sep 30, 2021 10-Q 2021-11-10
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.